Literature DB >> 32222421

Importing coronavirus disease 2019 (COVID-19) into China after international air travel.

Xiao-Ai Zhang1, Hang Fan1, Run-Zi Qi2, Wei Zheng3, Kui Zheng4, Jian-Hang Gong2, Li-Qun Fang1, Wei Liu5.   

Abstract

Entities:  

Keywords:  Case cluster; China; Coronavirus; Isolation and quarantine; Transmission

Mesh:

Year:  2020        PMID: 32222421      PMCID: PMC7102655          DOI: 10.1016/j.tmaid.2020.101620

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
Dear Editor, The epidemic of coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was originated from Wuhan, and spread rapidly nationwide, with some cases occurring in other parts of the world [[1], [2], [3], [4]]. As of Feb 29, 2020, 6009 cases related to Wuhan had been recorded from 53 countries, with some causing subsequent person to person transmission in the local regions [[4], [5], [6], [7], [8]] (https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf). The global spread of the SARS-CoV-2 associated with frequent global and regional travelling has greatly increased the possibility of causing global pandemics. Here we reported two case clusters of Chinese citizenship who were identified through inbound screening when returning from international travels. On the morning of Jan 22, 2020, a 26-year-old woman (Patient 1) returning China from Singapore was quarantined at Hangzhou Xiaoshan Airport (Fig. 1 and Table 1 ). The patient had fever of 37.1 °C and sore throat. Airport Customs quarantined the Patient 1 and other 8 close contracts, including her 25-years-old husband and 4-years-old daughter, 5 passengers who seated in the same row or 2 rows next to the row of Patient 1, and one flight attendant who had served the patient. Among all the close contacts, only her husband had symptom of sore throat. The swabs were collected from symptomatic Patient 1, her husband and daughter for SARS-CoV-2 test. Other 6 quarantined individuals, who were all asymptomatic, were not tested for SARS-CoV-2. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) disclosed positive SARS-CoV-2 result for Patient 1 and her husband (Patient 2), but negative for her daughter on Jan 22 (Appendix). The patient 1 had initial symptoms of fever and headache on January 16, which was resolved after taking medicine (Tylenol). Her family left China on Jan 19 for a four-day international tourism to Singapore. During their tourism, they stayed at the hotel without having close contacts with local persons. Her husband (Patient 2) developed illness on Jan 20 during their stay in Singapore and self-medication was taken on Jan 21. Their 4-years-old daughter remained healthy as of the end of 14-days quarantine on Feb 5. A retrospective tracing revealed close contacts of Patient 1 with two COVID-19 patients in Hangzhou on Jan 12–13 while attending a meeting. However, these patients were only confirmed one week after the meeting, when the Patient 1 had already been in Singapore. Her family members did not attend the meeting and had no other contacts with any confirmed case; therefore, her husband might acquire infection from Patient 1. Their 4-years-old daughter remained healthy to the end of 14-days quarantine as of Feb 5.
Fig. 1

Timeline of events and investigations associated with two clusters of COVID-19 cases among travellers returning to China. Dates filled in red are the dates of onset of illness. Dates filled in purple are the dates on which Patients 1–2 and their daughter had close contacts with COVID-19 patients. Dates filled in orange are the dates on which patients 3–11 stayed at Wuhan city. Dates filled in yellow are the dates on which patients 4–9 stayed at other areas of Hubei province except Wuhan. The white boxes with an internal red cross are the dates of positive qRT-PCR result detected by Hangzhou International Travel Healthcare Center. The white boxes with an internal red horizontal line are the dates of negative qRT-PCR result detected by Hangzhou International Travel Healthcare Center. The blue boxes with an internal red cross are the dates of confirmation of patients by Hangzhou Municipal Health Commission. qRT-PCR = quantitative reverse transcriptase polymerase chain reaction. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Table 1

Characteristics of patients with coronavirus disease 2019.

CharacteristicsFamily case cluster (Flight: NS3530)
Tour group case cluster (Flight: TR188)
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10Patient 11Patient 12
RelationshipWifeHusbandLeader of tour groupMother of patient 7Daughter of Patient 6Wife of patient 11Husband of patient 10
Age (years)262546263345205236333244
SexMaleFemaleMaleFemaleFemaleFemaleFemaleFemaleMaleFemaleMaleMale
Onset of illnessJan 16Jan 20Jan 24Jan 24Jan 24Jan 26Jan 26Jan 27Jan 27Jan 31Feb 2Feb 2
Confirmation dateJan 25Jan 28Jan 25Jan 25Jan 28Jan 30Feb 1Jan 28Feb 3Feb 9Feb 5Feb 3
Seat number56J56L12D11D31J44A12C44C31K11G11J31F
Clinical manifestations at onset
 FeverYesNoYesNoNoYesYesYesYesYesYesYes
 CoughNoNoNoNoNoNoNoNoYesNoYesNo
 HeadacheNoNoNoNoYesNoYesNoNoNoNoNo
 Sore throatYesYesNoYesNoNoNoNoNoNoNoNo
 Nasal congestionNoNoNoNoNoNoYesYesNoNoNoNo
 ExpectorationNoNoNoNoNoNoNoYesYesNoYesNo
 RhinorrheaNoNoNoNoNoNoNoNoNoNoNoNo
 DizzyNoNoNoNoNoNoNoNoNoNoNoYes
 FatigueNoNoNoNoNoNoNoNoNoNoNoYes
 Muscle sorenessNoNoNoNoNoYesNoNoNoNoNoNo
 ArthralgiaNoNoNoNoNoYesNoNoNoNoNoNo
 Radiological changes of lungNDNDNoNoNoNoYesNoNoNoYesYes

Abbreviation: ND, not done.

Timeline of events and investigations associated with two clusters of COVID-19 cases among travellers returning to China. Dates filled in red are the dates of onset of illness. Dates filled in purple are the dates on which Patients 1–2 and their daughter had close contacts with COVID-19 patients. Dates filled in orange are the dates on which patients 3–11 stayed at Wuhan city. Dates filled in yellow are the dates on which patients 4–9 stayed at other areas of Hubei province except Wuhan. The white boxes with an internal red cross are the dates of positive qRT-PCR result detected by Hangzhou International Travel Healthcare Center. The white boxes with an internal red horizontal line are the dates of negative qRT-PCR result detected by Hangzhou International Travel Healthcare Center. The blue boxes with an internal red cross are the dates of confirmation of patients by Hangzhou Municipal Health Commission. qRT-PCR = quantitative reverse transcriptase polymerase chain reaction. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Characteristics of patients with coronavirus disease 2019. Abbreviation: ND, not done. A second case cluster was found from a 110-person international tour group with destination to Singapore and Malaysia. The tour group flew from Wuhan to Singapore on Jan 20, 2020, with flight time of 10 hours. Then the group left Singapore to Malaysia on Jan 21 and returned to Hangzhou by a four-hour flight on Jan 24. In view of 110-person of Wuhan origin in the plane, rigorous symptomatic surveillance and quarantine measures were taken for all the passengers in the plane at Hangzhou Xiaoshan Airport on Jan 24. Among the quarantined passengers, 5 had symptoms (including fever, headache and sore throat), who were transferred to the COVID-19 designated hospital for treatment in Hangzhou after collecting their swabs for detection. Three of them (Patient 3–5) were subsequently tested positive for SARS-CoV-2 by qRT-PCR on Jan 25. All the other Chinese passengers in the plane, including remaining 105 Wuhan tour group members, 220 non-Wuhan passengers and 11 airline employees were asymptomatic and were separately quarantined as required. Other 18 Singaporean passengers and 10 airline employees of Singapore citizenship traveled back to Singapore without undergoing further quarantine procedures in China. All quarantined individuals were actively monitored for symptoms, and for those who reported illness, swabs were tested for SARS-CoV-2 infection by qRT-PCR. During their quarantine that last 14 days, another 7 (Patient 6–12) developed illness and their swabs were qRT-PCR positive for SARS-CoV-2. Six of them were from the Wuhan tour group, therefore an attack rate of 8.18% (9/110) for COVID-19 was deduced for the Wuhan tour group members. These patients included a 45-years-old woman (Patient 6) and her 20-years-old daughter (Patient 7) who had illness on Jan 26, a 52-years-old woman (Patient 8) and a 36-years-old man (Patient 9) who felt ill on Jan 27, a 33-years-old woman (Patient 10) who had illness on Jan 31 and her 32-years-old husband (Patient 11) on Feb 2. These patients involved two family case clusters, with the daughter of Patient 10 and Patient 11 remained healthy at the end of quarantine as of Feb 8, 2020, despite of close contact with her parent. Among 220 non-Wuhan passengers, one 44-years-old man (Patient 12), developed illness on Feb 2. This patient had no previous contact with any COVID-2019 patients, or had traveled to endemic region before this flight. He had seated neighboring Patient 5 and 9, therefore was postulated to acquire infection through contact with these patients, thus we postulate an attack rate of 0.45% (1/220) through short travel journal for the non-Wuhan passenger (Fig. 1 and Table 1). The next-generation sequencing yielded the full-length genome sequences of SARS-CoV-2 from Patient 2 (named 2019-nCoV IME-HZ01; accession number: MT039874; detailed in appendix), which consists of 29,859 nt with a G + C% content of 38%. The sequence shared a high similarity (>99%) with SARS-CoV-2 sequences available. The multiple alignment results showed 100% similarity with BatCoV/Wuhan/IVDC-HB-01/2019 (GISAID Accession ID EPI ISL 402119) and several other sequences (Fig. 2 and Appendix Table 1).
Fig. 2

Phylogenetic analysis of full-length genome of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) sequences with strain of Patient 2 (named 2019-nCoV IME-HZ01). GISAID accession number of each sequence was listed in the figure. 2019-nCoV IME-HZ01 strain was grouped with other strains from Wuhan and other locations.

Phylogenetic analysis of full-length genome of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) sequences with strain of Patient 2 (named 2019-nCoV IME-HZ01). GISAID accession number of each sequence was listed in the figure. 2019-nCoV IME-HZ01 strain was grouped with other strains from Wuhan and other locations. The incubation period is important for defining the period of public health observation of exposed contacts of confirmed cases. For the second case cluster, if supposing the last exposure to cases occurred on the day of quarantine, then the incubation period of the 9 patients ranged from 1 to 10 days, which was an obviously underestimation of the actual data. However, it is hard to make an accurate estimation on the incubation period, because the cases originated from areas with active COVID-19 transmission, so they could have gotten SARS-CoV-2 infection in Wuhan/Hubei before travel, or from each other during their 5-day tour in Singapore/Malaysia, or during the 5-h flight since transmission could have occurred anywhere in those periods of close contact. Still, travel screening procedures should thoroughly ascertain all travelers during the maximum incubation period (14 days, or more as the authors suggest, especially in view of the incubation period of 25 days in a recent study [9]. Our findings warn of necessity of not only outbound screening, but also inbound border screening for international travels. But our findings indicate that temperature screening alone is not an effective way to stop COVID-19 spread at exit or entry, since infected individuals may be in incubation period and not express apparent symptoms. In the second cluster, only Patient 3 had fever during inbound airport border screening. Consequently, early removal and isolation of ill passengers and quarantine of close contacts were effective to allow for a proper risk assessment and management of travelers at points of entry. Till the end of quarantine, two children remained well despite of similar level of close contact with the patients who are all confirmed COVID-19 cases. This phenomenon reinforced previous hypothesis of lower risk of acquiring infection for children than the adults [10]. However, since the child in the second cluster was not tested for SARS-CoV-2 and the child in the first cluster was only tested SARS-CoV-2 at the beginning of the 14-day quarantine period, but not again at the end, we cannot rule out the possibility of their asymptomatic infection. This result warrants further confirmation in future serological studies. In this study, public health investigation and contact tracing led to the identification of 9 confirmed cases of PCR-confirmed SARS-CoV-2 infection in Wuhan tour group. If taking into account the asymptomatic infection that was missed by merely symptomatic surveillance, the actual infection might be even higher. Additionally, non-Wuhan tour group Patient 12 is unique. With no Wuhan travel history and contact history of COVID-19 patients, the date of exposure for Patient 12 was most likely on the day of the flight (Jan 24) and the incubation period would be clearly defined as 9 days. The role of air travel in the transmission and dissemination of respiratory infections has been examined for severe acute respiratory syndrome (SARS) and Pandemic (H1N1) 2009 [11,12]. Our results suggested that SARS-CoV-2 transmission during air travel is possible, although the risk of spreading among passengers or through crew is low during flights of short journey. Still, health recommendations to travelers before and after travel should be strongly recommended and rigorously adopted, especially when China are now facing the high burden of imported SARS-CoV-2 infection from both Chinese citizens and foreign travelers.

CRediT authorship contribution statement

Xiao-Ai Zhang: Conceptualization, Data curation, Formal analysis, Supervision, Writing - review & editing. Hang Fan: Methodology, Formal analysis, Software, Writing - original draft. Run-Zi Qi: Data curation, Investigation, Resources. Wei Zheng: Data curation, Investigation, Resources. Kui Zheng: Data curation, Investigation, Resources. Jian-Hang Gong: Data curation, Investigation, Resources. Wei Liu: Conceptualization, Funding acquisition, Project administration, Supervision, Writing - review & editing.

Declaration of competing interest

The authors declare no conflicts of interest.
  10 in total

1.  Transmission of the severe acute respiratory syndrome on aircraft.

Authors:  Sonja J Olsen; Hsiao-Ling Chang; Terence Yung-Yan Cheung; Antony Fai-Yu Tang; Tamara L Fisk; Steven Peng-Lim Ooi; Hung-Wei Kuo; Donald Dah-Shyong Jiang; Kow-Tong Chen; Jim Lando; Kwo-Hsiung Hsu; Tzay-Jinn Chen; Scott F Dowell
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

2.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

3.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

4.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam.

Authors:  Lan T Phan; Thuong V Nguyen; Quang C Luong; Thinh V Nguyen; Hieu T Nguyen; Hung Q Le; Thuc T Nguyen; Thang M Cao; Quang D Pham
Journal:  N Engl J Med       Date:  2020-01-28       Impact factor: 91.245

6.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

7.  Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore.

Authors:  Pratik Mukherjee; Poh Lian Lim; Angela Chow; Timothy Barkham; Eillyne Seow; Mar Kyaw Win; Arlene Chua; Yee Sin Leo; Mark I Cheng Chen
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

8.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

9.  Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China.

Authors:  Zhanwei Du; Lin Wang; Simon Cauchemez; Xiaoke Xu; Xianwen Wang; Benjamin J Cowling; Lauren Ancel Meyers
Journal:  Emerg Infect Dis       Date:  2020-05-17       Impact factor: 6.883

10.  Going global - Travel and the 2019 novel coronavirus.

Authors:  Alfonso J Rodríguez-Morales; Kirsten MacGregor; Sanch Kanagarajah; Dipti Patel; Patricia Schlagenhauf
Journal:  Travel Med Infect Dis       Date:  2020-02-08       Impact factor: 6.211

  10 in total
  11 in total

1.  Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Among Air Passengers in China.

Authors:  Maogui Hu; Jinfeng Wang; Hui Lin; Corrine W Ruktanonchai; Chengdong Xu; Bin Meng; Xin Zhang; Alessandra Carioli; Yuqing Feng; Qian Yin; Jessica R Floyd; Nick W Ruktanonchai; Zhongjie Li; Weizhong Yang; Andrew J Tatem; Shengjie Lai
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  Recently spreading human monkeypox virus infection and its transmission during COVID-19 pandemic period: A travelers' prospective.

Authors:  Manojit Bhattacharya; Kuldeep Dhama; Chiranjib Chakraborty
Journal:  Travel Med Infect Dis       Date:  2022-06-29       Impact factor: 20.441

3.  Impact of lockdown to control over Novel Coronavirus and COVID-19 in India.

Authors:  Avadhesh Kumar Yadav
Journal:  J Family Med Prim Care       Date:  2020-10-30

4.  Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study.

Authors:  Wenliang Zhai; Zujin Luo; Yue Zheng; Dawei Dong; Endong Wu; Zhengfang Wang; Junpeng Zhai; Yujuan Han; Huan Liu; Yanran Wang; Yaohui Feng; Jing Wang; Yingmin Ma
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

5.  SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance.

Authors:  A Bak; M A Mugglestone; N V Ratnaraja; J A Wilson; L Rivett; S M Stoneham; J Bostock; S E Moses; J R Price; M Weinbren; H P Loveday; J Islam; A P R Wilson
Journal:  J Hosp Infect       Date:  2021-05-01       Impact factor: 3.926

6.  A stochastic contact network model for assessing outbreak risk of COVID-19 in workplaces.

Authors:  Xi Guo; Abhineet Gupta; Anand Sampat; Chengwei Zhai
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

7.  Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance.

Authors:  Moira A Mugglestone; Natasha V Ratnaraja; Aggie Bak; Jasmin Islam; Jennie A Wilson; Jennifer Bostock; Samuel E Moses; James R Price; Michael Weinbren; Heather P Loveday; Lucy Rivett; Simon M Stoneham; A Peter R Wilson
Journal:  BMC Infect Dis       Date:  2022-05-12       Impact factor: 3.667

8.  On the airborne transmission of SARS-CoV-2 and relationship with indoor conditions at a hospital.

Authors:  Zeynab Baboli; Niloofar Neisi; Ali Akbar Babaei; Mehdi Ahmadi; Armin Sorooshian; Yaser Tahmasebi Birgani; Gholamreza Goudarzi
Journal:  Atmos Environ (1994)       Date:  2021-06-21       Impact factor: 4.798

9.  Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?

Authors:  Carlo Torti; Maria Mazzitelli; Enrico Maria Trecarichi; Owachi Darius
Journal:  BMC Infect Dis       Date:  2020-06-15       Impact factor: 3.090

10.  New Coronavirus (SARS-CoV-2) Crossing Borders Beyond Cities, Nations, and Continents: Impact of International Travel.

Authors:  Pooja Arora; Sumit Mrig; Yaser Goldust; George Kroumpouzos; Ayşe Serap Karadağ; Lidia Rudnicka; Hassan Galadari; Jacek C Szepietowski; Vito Di Lernia; Andy Goren; Martin Kassir; Mohamad Goldust
Journal:  Balkan Med J       Date:  2021-07       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.